NIHR UCLH Biomedical Research Centre

Clinician researchers at @uclh & @ucl are leading a UK trial testing whether proton beam therapy could improve survival for people with mesothelioma, a rare aggressive lung cancer. The HIT-MESO trial aims to increase 2-year survival from ~30% to 50%. uclhospitals.brc.nihr.ac.uk/news/uclh-and-…

A new modelling study from researchers @ucl and the Severn Major Trauma Network suggests that patients urgently requiring a breathing tube are more likely to survive if the tube is inserted before arriving at hospital compared to insertion afterwards. uclhospitals.brc.nihr.ac.uk/news/breathing…

Sebastian Gomez, a medical student @UCLMS shared his story with @SkyNews, saying the technology gave him a “new piece of hope.” Read and watch more about his story ⬇️ news.sky.com/story/man-give…

🧠 There are now seven patients participating in the GB-PRIME study involving @neuralink's brain-computer interface technology. The technology aims to improve independence for those who are paralysed. All patients surgeries were conducted at @uclh. uclhospitals.brc.nihr.ac.uk/news/seven-pat…

📢 The UCLH Research Open Day is back! Be part of our interactive event, 9 July, showcasing healthcare advancements to the public. Teams are invited to apply to: - Demonstrate cutting-edge research - Encourage participation in research Apply now ⬇️ ucl.ac.uk/joint-research…

Happy Birthday, UCL 🎉 We're proud to be celebrating the strong collaboration between @ucl and @uclh, centred on our @NIHRresearch BRC, that continues to accelerate the translation of research into real-world healthcare innovation.

Man given Musk's Neuralink brain chip in UK trial says it 'feels magical' and gives new hope Science and technology editor @t0mclark3 reports trib.al/pa1rPW0

Register now! The @ucl Advanced Therapies Symposium returns on 22 April 2026.  This event brings together 250+ researchers, clinicians, funders & industry to explore breakthroughs from lab to market. More info: bit.ly/4aXnXTA #UCL2026AdvTx @UCLEnterprise @UCL_Business

✏️ Registration for our PPIE Workshops is now open The training aims to equip researchers with practical skills for meaningful patient and public involvement. Open to researchers across the UK and internationally. 💻 Virtual, Feb-June ⬇️ Book now uclhospitals.brc.nihr.ac.uk/involving-pati…

Men in England with high-risk locally advanced prostate cancer will soon be offered abiraterone on the NHS, following findings co-led by @uclh oncologist Prof Gert Attard. The trial showed treatment can halve the risk of death & slow disease progression. uclhospitals.brc.nihr.ac.uk/news/uclh-supp…

🚀 Bridging the Regulatory Gap in Medical Device Research @UCL researchers & innovators: Join us on 6 Feb for expert insights, case studies & networking to accelerate your path to commercialisation. 📍 UCL BaseKX | 🔗 Register: bit.ly/4ptWtIV

New research from experts at @ucl and @Cambridge_Uni highlights that individuals prescribed new-generation weight loss drugs may not be getting enough nutritional guidance - increasing the risk of nutrient deficiencies and muscle loss. uclhospitals.brc.nihr.ac.uk/news/lack-supp…

🎉 As we step into 2026, we’re taking a moment to celebrate a brilliant year for BRC-supported research at UCLH and UCL. From breakthrough discoveries to real-world impact, our exceptional research teams and delivery staff have achieved so much together.

From everyone at the @NIHRresearch UCLH Biomedical Research Centre, we wish our colleagues, researchers, partners, patient/public contributors and friends a Merry Christmas and all the best over the festive period 🎄

💉 Help find a vaccine against Paratyphoid A Fever We’re looking for volunteers to take part in the BiVISTA study @uclh. We’re recruiting: 👉 Healthy adults, aged 18-55 👉 Duration ~7 months 👉 Up to 31 visits at UCLH 👉 Reimbursement up to £4,410 uclhospitals.brc.nihr.ac.uk/healthy-volunt…

A new daily pill, baxdrostat, has shown sustained 24 hour blood pressure control for people whose condition is particularly difficult to manage. The global study was led by Professor Bryan Williams, @ucl. @NIHRresearch uclhospitals.brc.nihr.ac.uk/news/new-drug-…

A new @ucl-led analysis finds that sertraline, one of the most commonly prescribed antidepressants, improves key emotional symptoms of depression, including low mood and suicidal thoughts, within two weeks. uclhospitals.brc.nihr.ac.uk/news/antidepre…

Researchers at @uclh have recruited the first UK participant to BEHOLD-2, a global trial testing a novel anti-cancer treatment combination for advanced solid tumours, including endometrial and ovarian cancers. uclhospitals.brc.nihr.ac.uk/news/first-par…

A UCLH patient with multiple sclerosis is the first in the UK to receive CAR T cell therapy in a clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease. Read more: buff.ly/uRVxVHr Photo: Lucy North/PA

What a great commentary from Lutz Muller on our new Blood paper where we tested matched allo donor CARs for adult B-ALL alongside repeat CAR dosing. He is spot on when he says lymphodepletion is key! ⁦@uclh⁩ ⁦@UCLHresearch⁩ ⁦@uclcancer⁩ ashpublications.org/blood/article/…